Jan 09 2025 51 mins 1
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning had the opportunity to speak with the new Editor-in-Chief of the Journal of the American College of Surgeons (JACS), Dr. Tom Varghese, Jr. They discuss the types of journals and articles JACS publishes, hints and tips for submitting to JACS, and the future of JACS. They also discuss experiment reproducibility, negative clinical trials, and what studies should be conducted in the future.
Joel also reviews recent JANS articles on lung transplant outcome from selected older donors (≥70 years) equals younger donors (<70 years), initial experience with the da Vinci single-port system in patients with an anterior mediastinal mass, why and when do we invasively restage after neoadjuvant chemoimmunotherapy, and harmonizing guidelines and other clinical practice documents.
In addition, Joel explores a new episode of The Atrium with Dr. Alice Copperwheat and Dr. Valerie Rusch on finding success in surgery training and a presentation by Dr. Shaf Keshavjee on “Ex Vivo and In Vivo Systems to Support, Treat, and Engineer Organs.” Before closing, he highlights upcoming events in CT surgery.
JANS Items Mentioned
1.) Lung Transplant Outcome From Selected Older Donors (≥70 Years) Equals Younger Donors (<70 Years)
3.) Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?
CTSNET Content Mentioned
1.) The Atrium: Finding Success in Surgery Training
2.) ASAIO 2024 | Ex Vivo and In Vivo Systems to Support, Treat, and Engineer Organs
Other Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
